Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells-Reference-Cited by-同舟云学术

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells

Published:2014-04-16 Issue:12 Volume:28 Page:2355-2366
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Klar R,Schober S,Rami M,Mall S,Merl J,Hauck S M,Ueffing M,Admon A,Slotta-Huspenina J,Schwaiger M,Stevanović S,Oostendorp R A J,Busch D H,Peschel C,Krackhardt A M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014131.pdf

Reference56 articles.

1. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462–2465.

2. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990; 348: 252–254.

3. Hunt DF, Michel H, Dickinson TA, Shabanowitz J, Cox AL, Sakaguchi K et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992; 256: 1817–1820.

4. Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18: 1254–1261.

5. Bassani-Sternberg M, Barnea E, Beer I, Avivi I, Katz T, Admon A . Feature Article: Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc Natl Acad Sci USA 2010; 107: 18769–18776.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of T Cell Epitopes for Cancer Immunotherapy;Interdisciplinary Cancer Research;2024

2. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models;Advanced Drug Delivery Reviews;2021-12

3. Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia;Cancers;2021-09-08

4. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma;Journal for ImmunoTherapy of Cancer;2021-09

5. Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia;Cytotherapy;2021-09